The Office of Human Research Protection is the support structure for the Institutional Review Board (IRB). The office works with investigators to protect the rights and welfare of research participants. Staff pre-reviews submissions to the Institutional Review Board, providing feedback, consultation, and interpretation of applicable regulations.
The Institutional Review Board supervises a varied, high-volume body of research, ranging from pioneering therapies to chart reviews. IRB-supervised research helps to attract and retain a wide range of specialists who offer the latest expertise in patient care.
IRBs are responsible for ensuring that patients’ rights and safety are protected throughout the process. Everything from the language in a consent form to the dosage and administration of new drugs is scrutinized. An IRB committee is made up of physicians, nurses, pharmacists, clergy, and community members who volunteer their time to review proposals for new research and to review existing clinical trials. At GHS, there are three IRB committees.
- IRB Committee A – Reviews all types of research except oncology
- IRB Committee B – Reviews all pediatric research, as well as additional research, as needed (except adult oncology)
- IRB Committee C – Reviews adult oncology research
Quick Start Guide New
QI Frequently Asked Questions New
QI Guidance New
New Learner Account Registration – CITI
Policies and Procedures Manual
HRPP Policy 801 – Conflicts of Interest in Research
HRPP Policy 33.02 – Western IRB
HRPP Policy 901 – Principal Investigator (PI) Responsibilities
Request for Submission to WIRB Form
Informed Consent Guidance Document
GHS eIRB Press Release
Is your study registered? Should it be?
CFR 21 Part 11 Compliance from Click Commerce
GHS Corporate Compliance Letter
GHS Exempt Reveiw Policy New